InVivo Biosystems
- Biotech or pharma, therapeutic R&D
InVivo Biosystems is developing novel therapeutics to support rare disease patients using our proprietary platform, RapidGen. RapidGen drastically multiplies in vivo throughput using AI phenotyping and multiplexed delivery of CRISPR guide RNAs and oligomers, providing high-value target discovery in CNS, ophthalmology, and metabolic disease areas.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}